Low vitamin D may increase your risk of being hospitalized with COVID-19

by University of South Australia

edited by Lisa Lock, reviewed by Andrew Zinin

Study: Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Image Credit: Kavun Halyna / Shutterstock.
Credit: Unsplash/CC0 Public Domain

As the latest wave of COVID-19 shows no signs of abating, University of South Australia experts say it’s not just booster shots that could offer protection—healthy levels of vitamin D may also play a role.

In new research published in PLOS One, conducted in partnership with King’s College London and Guy’s and St Thomas’ NHS Foundation, researchers found a clear link between low vitamin D levels and an increased risk of being hospitalized by the virus. No association was found between low vitamin D and the risk of catching COVID-19.

The study assessed 151,543 people in the UK Biobank, undertaking analyses to determine whether the risk of COVID-19 was higher among people with vitamin D deficiency (<25nmol/L in their blood) and vitamin D insufficiency (25–49 nmol/L) compared with those who had normal levels of vitamin D (50+ nmol/L). They also compared risk of being hospitalized due to COVID-19 across these three groups.

In Australia, nearly a quarter of adults—about 4 million people—are vitamin D deficient. Globally, about 1 billion people have vitamin D deficiency, with 50% of the population showing insufficient vitamin D levels.

Australian-based researcher and epidemiologist, UniSA’s Dr. Kerri Beckmann, says the findings could identify vulnerable people and guide future public health advice.

“Vitamin D plays a key role in regulating the immune system, so it’s plausible that low levels may influence how the body responds to infections like COVID-19,” Dr. Beckmann says.

“Our study found that people with a vitamin D deficiency or insufficiency were more likely to be hospitalized with COVID-19 than those with healthy levels of vitamin D—but they weren’t more likely to catch the virus in the first place.”

The study also explored associations between vitamin D and COVID-19 outcomes among cancer patients, as well as across different ethnic groups.

People of Asian or African/Afro-Caribbean heritage were found to have a slightly higher risk of infection if they had low vitamin D levels, though the association between low vitamin D and severe illness was only seen in people of Caucasian backgrounds.

No association was found between vitamin D and COVID-19 outcomes among people previously diagnosed with cancer, though researchers caution this may reflect the smaller sample size.

Dr. Beckmann says that while risk from COVID-19 has lessened over time, the virus remains a public health concern.

“COVID-19 may not be the threat it once was, but it still affects peoples’ well-being,” Dr. Beckmann says. “Understanding who is most at risk helps those individuals take extra precautions, including monitoring their vitamin D levels.

“It could be that people who are in poor health to start with may also have low vitamin D levels. So, at this stage, we don’t know whether vitamin D supplements in themselves could reduce the severity of COVID-19.

“It’s certainly an area worth exploring—especially as we continue to live with the virus.”

More information: Maria J. Monroy-Iglesias et al, Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobank, PLOS One (2025). DOI: 10.1371/journal.pone.0328232

Journal information: PLoS ONE
Provided by University of South Australia

Explore further

Is there a connection between vitamin D deficiency and COVID-19?

Facebook
Twitter
LinkedIn
Pinterest
Email

Related Posts

What is hyperphosphatemia?

Symptoms Causes Diagnosis Treatment Prevention Outlook Excess phosphate in the blood is known as hyperphosphatemia. The most common cause is kidney disease, but other conditions

Read More »
Scroll to Top